A Phase III Double Blind, Multi-Center Placebo Controlled Maintenance Trial of HMPL-004 in Subjects With Mild to Moderate Ulcerative Colitis With Clinical Remission or Response From Induction Therapy. (NATRUL-4)

Trial Profile

A Phase III Double Blind, Multi-Center Placebo Controlled Maintenance Trial of HMPL-004 in Subjects With Mild to Moderate Ulcerative Colitis With Clinical Remission or Response From Induction Therapy. (NATRUL-4)

Discontinued
Phase of Trial: Phase III

Latest Information Update: 08 May 2015

At a glance

  • Drugs HMPL 004 (Primary)
  • Indications Ulcerative colitis
  • Focus Registrational; Therapeutic Use
  • Acronyms NATRUL-4
  • Sponsors Hutchison MediPharma
  • Most Recent Events

    • 05 May 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov
    • 22 Jul 2013 New trial record
    • 17 Jul 2013 Status changed from not yet recruiting to recruiting based on information reported in a Nutrition Science Partners media release. The first patient has been treated.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top